MDLN
Medline Inc.
$40.30
-2.71 (-6.30%)
At close · Jul 8
Market Cap
$53.66B
Shares
1,313,688,164
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$28.43B
+11.5%
FY2025
Net Income
$1.16B
-0.3%
FY2025
Gross Margin
26.44%
-0.9pp
FY2025
Operating Margin
7.78%
-0.6pp
FY2025
Diluted EPS
-$0.01
FY2025
Operating Cash Flow
$1.74B
-1.4%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| $28.43B | $25.51B | $23.23B | |
| $17M | $15M | $17M | |
| $20.91B | $18.53B | $17.35B | |
| $7.52B | $6.98B | $5.89B | |
| 26.44% | 27.35% | 25.33% | |
| $80M | $67M | $60M | |
| $4.52B | $4.11B | $3.87B | |
| $704M | $685M | $662M | |
| $1.01B | $977M | $951M | |
| $5.31B | $4.83B | $4.64B | |
| $2.21B | $2.15B | $1.25B | |
| 7.78% | 8.41% | 5.38% | |
| $3.22B | $3.12B | $2.2B | |
| $945M | $1.14B | $1.21B | |
| $133M | $280M | $237M | |
| -$964M | -$900M | -$986M | |
| $1.25B | $1.25B | $264M | |
| $91M | $46M | $30M | |
| $1.16B | $1.16B | $234M | |
| 4.08% | 4.56% | 1.01% | |
| -$2M | — | — | |
| -$7M | — | — | |
| $1.19B | $1.02B | $160M | |
| USD/shares | -$0.01 | — | — |
| USD/shares | -$0.01 | — | — |
| shares | 810M | — | — |
| shares | 810M | — | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2023–FY2025: $53M in buybacks.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Supply Chain Solutions Segment | $14,712,000,000 | $12,992,000,000 | $11,618,000,000 |
| Medline Brand Segment | $13,720,000,000 | $12,515,000,000 | $11,613,000,000 |
By Geography (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| United States | $26,479,000,000 | $23,747,000,000 | $21,800,000,000 |
| Non Us | $1,953,000,000 | $1,760,000,000 | $1,431,000,000 |